Cargando…
Antimicrobial Activity of a Triple Antibiotic Combination Toward Ocular Pseudomonas aeruginosa Clinical Isolates
PURPOSE: Pseudomonas aeruginosa is a leading cause of corneal infections. Recently, we discovered an antimicrobial drug combination, polymyxin B/trimethoprim (PT) + rifampin, that displayed impressive efficacy toward P. aeruginosa in both in vitro and in vivo studies. As such, this combination was f...
Autores principales: | Mei, Jia A., Johnson, William, Kinn, Bailey, Laskey, Emily, Nolin, Lydia, Bhamare, Pratham, Stalker, Charlotte, Dunman, Paul M., Wozniak, Rachel A. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145016/ https://www.ncbi.nlm.nih.gov/pubmed/35612831 http://dx.doi.org/10.1167/tvst.11.5.26 |
Ejemplares similares
-
Evaluating the Antimicrobial Properties of Commercial Hand Sanitizers
por: Chojnacki, M., et al.
Publicado: (2021) -
Sub-Inhibitory Antibiotic Exposure and Virulence in Pseudomonas aeruginosa
por: Nolan, Charlotte, et al.
Publicado: (2021) -
Responses of Pseudomonas aeruginosa to antimicrobials
por: Morita, Yuji, et al.
Publicado: (2014) -
Tolerance and Resistance of Pseudomonas aeruginosa Biofilms to Antimicrobial Agents—How P. aeruginosa Can Escape Antibiotics
por: Ciofu, Oana, et al.
Publicado: (2019) -
Antimicrobial Efficiency of Some Essential Oils in Antibiotic-Resistant Pseudomonas aeruginosa Isolates
por: Van, Luc Tran, et al.
Publicado: (2022)